Over 118 million new cancer cases and 9.6 million deaths are recorded in 2018. There is still no perfect cure found for this disease. Many health and tech giants are investing in cancer research and there have been many accomplishments and many to go for a final end to cancer.
IBM has devoted quite some time and funds in cancer research and has hit many milestones. In its current success portfolio, IBM is presenting three machine learning based application to fight cancer.
1. PaccMan: PaccMan tool helps in predicting and explaining the efficacy of drugs.
Paper: https://arxiv.org/abs/1904.11223
Source: https://www.ibm.com/blogs/research/2019/07/ai-tools-for-cancer-research/
2. INtERAcT: This tool automates knowledge extraction from research papers.
Paper: https://www.nature.com/articles/s42256-019-0036-1.epdf?
Source: https://www.ibm.com/blogs/research/2019/07/ai-tools-for-cancer-research/
3. PIMKL: This tool helps to interpret phenotype predictions using pathway information.
Paper: https://www.nature.com/articles/s41540-019-0086-3
Source: https://www.ibm.com/blogs/research/2019/07/ai-tools-for-cancer-research/
Continue Reading…. https://www.ibm.com/blogs/research/2019/07/ai-tools-for-cancer-research/
Asif Razzaq is the CEO of Marktechpost, LLC. As a visionary entrepreneur and engineer, Asif is committed to harnessing the potential of Artificial Intelligence for social good. His most recent endeavor is the launch of an Artificial Intelligence Media Platform, Marktechpost, which stands out for its in-depth coverage of machine learning and deep learning news that is both technically sound and easily understandable by a wide audience. The platform boasts of over a million monthly views, illustrating its popularity among audiences.
